Testosterone and docetaxel treatment effect on mortality risk in nonmetastatic high-risk prostate cancer: A predictive biomarker analysis. Zeng J, Chen MH, Wu J, Xie W, et al. Cancer 2026;132:e70469.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zeng J, Chen MH, Wu J, Xie W, et al. Testosterone and docetaxel treatment effect on mortality risk in nonmetastatic high-risk prostate cancer: A predictive biomarker analysis. Cancer 2026;132:e70469.
PMID: 42175549